{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:32Z","timestamp":1767135092940,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012590","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000}}],"reference-count":80,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012590.pub2","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T15:12:11Z","timestamp":1536160331000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Head-to-head trials of antibiotics for bronchiectasis"],"prefix":"10.1002","volume":"2018","author":[{"given":"Axel","family":"Kaehne","sequence":"first","affiliation":[{"name":"Edge Hill University; EPRC, Faculty of Health and Social Care; Ormskirk UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Milan","sequence":"additional","affiliation":[{"name":"Lancaster University; Medical School; Lancaster UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambert M","family":"Felix","sequence":"additional","affiliation":[{"name":"University of Oxford; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS); Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emer","family":"Sheridan","sequence":"additional","affiliation":[{"name":"Lancashire Teaching Hospitals NHS Foundation Trust; Pharmacy; Preston UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A","family":"Marsden","sequence":"additional","affiliation":[{"name":"Lancashire Teaching Hospitals Trust; Department of Respiratory Medicine; Preston UK"},{"name":"Lancaster University; Faculty of Health and Medicine; Lancaster UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Spencer","sequence":"additional","affiliation":[{"name":"Edge Hill University; Postgraduate Medical Institute; St Helens Road Ormskirk Lancashire UK L39 4QP"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD012590.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000239435","article-title":"Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong","volume":"42","author":"Chan","year":"1996","journal-title":"Chemotherapy"},{"issue":"Suppl 58","key":"10.1002\/14651858.CD012590.pub2-BIB0002|cit2","first-page":"P244","article-title":"Non-CF bronchiectasis: the effect of inhaled antibiotics (tobramycin and colistin) in patients with Pseudomonas aeruginosa","volume":"44","author":"Dimakou","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"Suppl 61","key":"10.1002\/14651858.CD012590.pub2-BIB0003|cit3","first-page":"OA1971","article-title":"Eradication treatment in non-CF bronchiectasis: the effect of inhaled antibiotics (tobramycin and colistin) on patients with Pseudomonas aeruginosa","volume":"50","author":"Kaponi","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0954-6111(89)80200-8","article-title":"Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis","volume":"83","author":"Lam","year":"1989","journal-title":"Respiratory Medicine"},{"issue":"53","key":"10.1002\/14651858.CD012590.pub2-BIB0005|cit5","first-page":"2995","article-title":"[Studies of the clinical and respiratory functional effects of a mucolytic-antibiotic preparation in chronic bronchopulmonary diseases. Controlled double-blind single code studies]","volume":"59","author":"Alberto","year":"1968","journal-title":"Minerva Medica"},{"issue":"Suppl 18","key":"10.1002\/14651858.CD012590.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"56P","DOI":"10.1042\/cs074056Pa","article-title":"Amoxycillin with and without probenecid in the management of patients with bronchiectasis","volume":"74","author":"Allen","year":"1988","journal-title":"Clinical Science"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2125.2000.00105.x","article-title":"The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing","volume":"49","author":"Begg","year":"2000","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD012590.pub2-BIB0008|cit8","first-page":"466","article-title":"[Comparative study of the clinical activity of tetracycline and a combination of tetracycline and thiamphenicol in respiratory tract infections. Controlled study of a cooperative type]","volume":"64","author":"Bevilacqua","year":"1973","journal-title":"Minerva Medica"},{"issue":"5","key":"10.1002\/14651858.CD012590.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012590.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1136\/thoraxjnl-2011-201054b.106","article-title":"S106\u2005A randomised double blind 13 week crossover trial of hypertonic saline (HTS) (6%) vs isotonic saline (ITS) (0.9%) in patients with bronchiectasis","volume":"66","author":"Bradley","year":"2011","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD012590.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01967062","article-title":"Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections","volume":"11","author":"Brambilla","year":"1992","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0012|cit12","first-page":"345","article-title":"Long-term treatment of bronchiectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture","volume":"103","author":"Cherniack","year":"1959","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/3.1.150","article-title":"Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract","volume":"3","author":"Finegold","year":"1981","journal-title":"Reviews of Infectious Diseases"},{"issue":"Suppl B","key":"10.1002\/14651858.CD012590.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jac\/14.suppl_B.301","article-title":"A comparison of cefotaxime and cefoperazone in respiratory tract infections","volume":"14","author":"Garcia-Rodriguez","year":"1984","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012590.pub2-BIB0015|cit15","first-page":"A173","article-title":"Randomised controlled study of levofloxacin versus ceftazidime in acute exacerbations of bronchiectasis","volume":"157","author":"Ip","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000319952","article-title":"A multicenter, randomized controlled clinical study on biapenem and imipenem\/cilastatin injection in the treatment of respiratory and urinary tract infections","volume":"56","author":"Jia","year":"2010","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD012590.pub2-BIB0017|cit17","first-page":"338","article-title":"Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG)","volume":"53","author":"Khan","year":"2003","journal-title":"Journal of the Pakistan Medical Association"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0018|cit18","first-page":"525","article-title":"Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections","volume":"58","author":"Kobayashi","year":"1984","journal-title":"Journal of the Japanese Association for Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12890-016-0261-x","article-title":"Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia","volume":"16","author":"Kobbernagel","year":"2016","journal-title":"BMC Pulmonary Medicine"},{"issue":"25","key":"10.1002\/14651858.CD012590.pub2-BIB0020|cit20","first-page":"927","article-title":"Comparative evaluation of certain antibiotics and Biceptol preparation in the treatment of chronic bronchial disease exacerbations","volume":"36","author":"Krawczyk","year":"1981","journal-title":"Polski Tygodnik Lekarski"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD012590.pub2-BIB0021|cit21","first-page":"88S","article-title":"Intermittent antibiotic treatment in patients with stable bronchiectasis: a comparative study between amoxycillin and cefonicid","author":"Lioberes","year":"1990","journal-title":"European Respiratory Journal"},{"issue":"11","key":"10.1002\/14651858.CD012590.pub2-BIB0022|cit22","first-page":"824","article-title":"Impact of treatment with low dose roxithromycin on stable bronchiectasis","volume":"35","author":"Liu","year":"2012","journal-title":"Chinese Journal of Tuberculosis and Respiratory Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0023|cit23","first-page":"251","article-title":"Comparative study of amoxycillin and amoxycillin\/clavulanic acid in lower respiratory infections","volume":"39","author":"Mehta","year":"1991","journal-title":"Journal of the Association of Physicians of India"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0024|cit24","first-page":"451","article-title":"Comparison of 5 day short-course therapies for secondary infection in patients with chronic respiratory disease using gatifloxacin and levofloxacin","volume":"55","author":"Nakamura","year":"2007","journal-title":"Japanese Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0025|cit25","unstructured":"NCT03058718 Effectiveness of procalcitonin-guided antibiotic therapy in acute exacerbations of bronchiectasis: a randomized controlled trial clinicaltrials.gov\/show\/NCT03058718"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0026|cit26","unstructured":"NCT03093974 Trial in non-cystic fibrosis bronchiectasis patients with chronic lung infections treated with colistimethate sodium (PROMIS-I) clinicaltrials.gov\/ct2\/show\/record\/NCT03093974"},{"issue":"5423","key":"10.1002\/14651858.CD012590.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.2.5423.1495","article-title":"Controlled comparison of lymecycline with tetracycline hydrochloride in exacerbations of chronic bronchitis","volume":"2","author":"Pines","year":"1964","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD012590.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0007-0971(67)80033-0","article-title":"Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis: controlled trials of increasing dosage of cephaloridine","volume":"61","author":"Pines","year":"1967","journal-title":"British Journal of Diseases of the Chest"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000238016","article-title":"Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections","volume":"27","author":"Pines","year":"1981","journal-title":"Chemotherapy"},{"issue":"48","key":"10.1002\/14651858.CD012590.pub2-BIB0030|cit30","first-page":"1823","article-title":"[Trimethoprim-sulfamethoxazole versus amoxycillin in the therapy of acute bacterial exacerbations in chronic non-specific respiratory tract diseases. A controlled study]","volume":"111","author":"Ramer","year":"1981","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012590.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.1007\/BF01661296","article-title":"A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis","volume":"14","author":"Lam","year":"1986","journal-title":"Infection"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1745-6215-13-156","article-title":"Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial","volume":"13","author":"Chang","year":"2012","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1745-6215-14-53","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD012590.pub2-BIB0034|cit34","first-page":"pii","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"52","author":"Ara\u00fajo","year":"2018","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.2002.tb04733.x","article-title":"Bronchiectasis in indigenous children in remote Australian communities","volume":"177","author":"Chang","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ppul.10289","article-title":"Non-CF bronchiectasis: clinical and HRCT evaluation","volume":"35","author":"Chang","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0039|cit39","article-title":"A new look at the pathogenesis and management of persistent bronchial sepsis: a Viscious Cycle hypothesis and its logical therapeutic connotations","volume-title":"Strategies for the Management of Chronic Bronchial Sepsis","author":"Cole","year":"1984"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0040|cit40","first-page":"6-15","article-title":"Inflammation: a two-edged sword--the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"European Journal of Respiratory Diseases"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0041|cit41","unstructured":"Deeks JJ Higgins JPT Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012733","article-title":"Continuous versus intermittent antibiotics for bronchiectasis","author":"Donovan","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/thx.2003.011577","article-title":"The need to re-define non-cystic fibrosis bronchiectasis in childhood","volume":"59","author":"Eastham","year":"2004","journal-title":"Thorax"},{"issue":"8","key":"10.1002\/14651858.CD012590.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0954-6111(03)00063-5","article-title":"Long-term antibiotics in the management of non-CF bronchiectasis - do they improve outcome?","volume":"97","author":"Evans","year":"2003","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012514","article-title":"Dual antibiotics for bronchiectasis","author":"Felix","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012590.pub2-BIB0047|cit47","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"Goeminne","year":"2012","journal-title":"Respiratory Research"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1183\/13993003.01567-2015","article-title":"Bronchiectasis: how to be an orphan with many parents?","volume":"47","author":"Goeminne","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0050|cit50","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/1817-1737.82443","article-title":"Clinical, radiologic, and functional evaluation of 304 patients with bronchiectasis","volume":"6","author":"Habesoglu","year":"2011","journal-title":"Annals of Thoracic Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012590.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011825","article-title":"Adverse events in patients taking macrolide antibiotics versus placebo for any indication","author":"Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0053|cit53","unstructured":"Higgins JPT Altman DG Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8. Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"250","key":"10.1002\/14651858.CD012590.pub2-BIB0054|cit54","first-page":"163","article-title":"The response of patients with purulent bronchiectasis to antibiotics for four months","volume":"66","author":"Hill","year":"1988","journal-title":"Quarterly Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012590.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1700051","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40258-013-0027-z","article-title":"Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective","volume":"11","author":"Joish","year":"2013","journal-title":"Applied Health Economics and Health Policy"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.11-0679","article-title":"The burden of disease in pediatric non-cystic fibrosis bronchiectasis","volume":"141","author":"Kapur","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012406.pub2","article-title":"Macrolide antibiotics for bronchiectasis","author":"Kelly","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012590.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"issue":"5","key":"10.1002\/14651858.CD012590.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012590.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e1002028","DOI":"10.1371\/journal.pmed.1002028","article-title":"Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study","volume":"13","author":"Page","year":"2016","journal-title":"PLoS Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012590.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"i1-58","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD012590.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0066|cit66","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.rmed.2010.02.022","article-title":"Trends in bronchiectasis mortality in England and Wales","volume":"104","author":"Roberts","year":"2010","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12. Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD012590.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.11-2209","article-title":"Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000-2007","volume":"142","author":"Seitz","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T","article-title":"Bronchiectasis in Alaska Native children: causes and clinical courses","volume":"29","author":"Singleton","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012579","article-title":"Oral versus inhaled antibiotics for bronchiectasis","author":"Spencer","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \"too high\" for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Paediatrics"},{"issue":"7","key":"10.1002\/14651858.CD012590.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010337.pub2","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012590.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"205-9","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clinical Pulmonary Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012590.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson","year":"1997","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD012590.pub2-BIB0078|cit78","doi-asserted-by":"crossref","DOI":"10.1183\/1025448x.10017912","article-title":"Definition and aetiology of non-CF bronchiectasis","volume-title":"The Spectrum of Bronchial Infection","author":"Wilson","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"321-9","DOI":"10.1111\/resp.12233","article-title":"Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2014","journal-title":"Respirology"},{"issue":"3","key":"10.1002\/14651858.CD012590.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012590","article-title":"Head-to-head trials of antibiotics for non-cystic fibrosis bronchiectasis","author":"Kaehne","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012590.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T07:33:24Z","timestamp":1653204804000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012590.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":80,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012590.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}